- Home
- NMRA vs POET Comparison
NMRA vs POET Comparison
Compare NMRA & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- POET
- Stock Information
- Founded
- NMRA 2019
- POET 1972
- Country
- NMRA United States
- POET Canada
- Employees
- NMRA N/A
- POET N/A
- Industry
- NMRA
- POET Semiconductors
- Sector
- NMRA
- POET Technology
- Exchange
- NMRA Nasdaq
- POET Nasdaq
- Market Cap
- NMRA 287.6M
- POET 275.1M
- IPO Year
- NMRA 2023
- POET N/A
- Fundamental
- Price
- NMRA $1.13
- POET $4.07
- Analyst Decision
- NMRA Buy
- POET Strong Buy
- Analyst Count
- NMRA 8
- POET 2
- Target Price
- NMRA $10.14
- POET $6.25
- AVG Volume (30 Days)
- NMRA 1.3M
- POET 1.2M
- Earning Date
- NMRA 03-03-2025
- POET 05-14-2025
- Dividend Yield
- NMRA N/A
- POET N/A
- EPS Growth
- NMRA N/A
- POET N/A
- EPS
- NMRA N/A
- POET N/A
- Revenue
- NMRA N/A
- POET $119,946.00
- Revenue This Year
- NMRA N/A
- POET N/A
- Revenue Next Year
- NMRA N/A
- POET $7,600.00
- P/E Ratio
- NMRA N/A
- POET N/A
- Revenue Growth
- NMRA N/A
- POET N/A
- 52 Week Low
- NMRA $1.13
- POET $1.00
- 52 Week High
- NMRA $17.19
- POET $7.79
- Technical
- Relative Strength Index (RSI)
- NMRA 26.07
- POET 49.90
- Support Level
- NMRA $1.13
- POET $3.80
- Resistance Level
- NMRA $1.23
- POET $4.65
- Average True Range (ATR)
- NMRA 0.12
- POET 0.33
- MACD
- NMRA 0.05
- POET 0.11
- Stochastic Oscillator
- NMRA 3.54
- POET 62.58
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The group's operations are located in Allentown, PA, Shenzhen, China, and Singapore.